Andrades, Rejane D.

HRN: 10/13/28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
CO-AMOXICLAV 625MG (TAB)
06/11/2023
06/17/2023
PO
625mg
BID
Threatened Abortion
Waiting Final Action 
06/12/2023
CEFTRIAXONE 1G (VIAL)
06/12/2023
06/19/2023
IV
2 Grams
Once Daily
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: